Quality of life in patients treated for COVID-19-associated mucormycosis at a tertiary care hospital
Description
                CONCLUSION: Approximately 1 in 2 patients with CAM had poor QOL and poor improvement. Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients
          